Baglivo, M.* ; Nasca, A.* ; Lamantea, E.* ; Vinci, S.* ; Spagnolo, M.* ; Marchet, S.* ; Prokisch, H. ; Catania, A.* ; Lamperti, C.* ; Ghezzi, D.*
Evaluation of mitochondrial dysfunction and idebenone responsiveness in fibroblasts from Leber's hereditary optic neuropathy (LHON) subjects.
Int. J. Mol. Sci. 24:11 (2023)
Leber's hereditary optic neuropathy (LHON) is a disease that affects the optical nerve, causing visual loss. The diagnosis of LHON is mostly defined by the identification of three pathogenic variants in the mitochondrial DNA. Idebenone is widely used to treat LHON patients, but only some of them are responders to treatment. In our study, we assessed the maximal respiration rate (MRR) and other respiratory parameters in eight fibroblast lines from subjects carrying LHON pathogenic variants. We measured also the effects of idebenone treatment on cell growth and mtDNA amounts. Results showed that LHON fibroblasts had significantly reduced respiratory parameters in untreated conditions, but no significant gain in MRR after idebenone supplementation. No major toxicity toward mitochondrial function and no relevant compensatory effect in terms of mtDNA quantity were found for the treatment at the tested conditions. Our findings confirmed that fibroblasts from subjects harboring LHON pathogenic variants displayed impaired respiration, regardless of the disease penetrance and severity. Testing responsiveness to idebenone treatment in cultured cells did not fully recapitulate in vivo data. The in-depth evaluation of cellular respiration in fibroblasts is a good approach to evaluating novel mtDNA variants associated with LHON but needs further evaluation as a potential biomarker for disease prognosis and treatment responsiveness.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Lhon ; Leber’s Hereditary Optic Neuropathy ; Biomarker ; Fibroblasts ; Idebenone ; Mtdna ; Responsiveness; Nqo1
Keywords plus
Language
english
Publication Year
2023
Prepublished in Year
0
HGF-reported in Year
2023
ISSN (print) / ISBN
1661-6596
e-ISSN
1422-0067
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 24,
Issue: 16,
Pages: ,
Article Number: 11
Supplement: ,
Series
Publisher
MDPI
Publishing Place
Basel
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30205 - Bioengineering and Digital Health
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-503292-001
Grants
Cell Line and DNA Bank of Genetic Movement Disorders and Mitochondrial Diseases" of the Telethon Network of Genetic Biobanks
The "Cell Line and DNA Bank of Genetic Movement Disorders and Mitochondrial Diseases" of the Telethon Network of Genetic Biobanks (GTB18001) and the EuroBioBanK Network supplied the biological specimens.
Copyright
Erfassungsdatum
2023-10-06